QurAlis is pioneering the path to conquering ALS and other neurodegenerative diseases.
Our proprietary platforms and unique biomarkers enable the design and development of precision medicines that act directly on disease-causing genetic alerations. We are agnostic about drug modalities and are always seeking new partnerships and technologies. To support our cause, we welcome partners who want to follow this path with us together. We are interested in building relationships with institutional and strategic investors, pharmaceutical companies, academia, and above all, families, who have traveled this road before us.